Plicamycin Uses, Dosage & Side Effects Explained

Summary of Key Points

Plicamycin, also known by its brand name Mithracin, is a chemotherapy medication used to treat various cancers, including testicular and breast cancer, as well as bone-related conditions like hypercalcemia. This antineoplastic agent works by slowing the growth of cancer cells. Plicamycin is typically administered in a hospital setting under the close supervision of healthcare professionals. Always consult your healthcare provider before starting or adjusting your treatment. For personalized advice, consider reaching out to one of our telemedicine providers today.

Names of the Medication

US Brand Name: Mithracin

Generic Name: Plicamycin

The generic name, Plicamycin, refers to the active ingredient in the medication. It is often listed alongside the brand name in parentheses.

Pharmacologic Category

Plicamycin is classified under the following pharmacologic categories:

1. Antineoplastic Agent
2. Antibiotic, Antineoplastic

Plicamycin Dosage Guidelines

Plicamycin is prescribed to treat several types of cancer and related conditions. The dosage depends on the specific condition being addressed. Always follow your healthcare provider’s instructions carefully, and never adjust your dose without consulting them first. If you have questions or need support, our telemedicine providers are here to assist you.

1. Testicular Cancer: 25 to 30 mcg/kg/day, administered intravenously (IV) for 3 to 5 days. Treatment cycles may be repeated after a break, depending on your response and any side effects.
2. Hypercalcemia (high calcium levels): 15 to 25 mcg/kg/day, administered IV for 3 to 4 days. Your doctor will monitor your calcium levels and adjust the dosage as needed.
3. Osteosarcoma: 25 to 30 mcg/kg/day, administered IV for 3 to 5 days. Treatment may be repeated based on your response to therapy.
4. Lymphoma: 25 mcg/kg/day, administered IV for 3 to 5 days. Your doctor will determine the appropriate duration of treatment.
5. Breast Cancer: 25 mcg/kg/day, administered IV for 3 to 5 days. Additional treatment cycles may be recommended as needed.
6. Kaposi’s Sarcoma: 25 mcg/kg/day, administered IV for 3 to 5 days. Your doctor will decide if further cycles are necessary.
7. Multiple Myeloma: 25 mcg/kg/day, administered IV for 3 to 5 days. Treatment may be repeated based on your condition and response.
8. Ewing’s Sarcoma: 25 mcg/kg/day, administered IV for 3 to 5 days. Your healthcare provider will monitor your progress and adjust the treatment plan as needed.
9. Choriocarcinoma: 25 mcg/kg/day, administered IV for 3 to 5 days. Treatment cycles may be repeated depending on your response.
10. Wilms’ Tumor: 25 mcg/kg/day, administered IV for 3 to 5 days. Your doctor will determine the appropriate length of treatment.

Dosage Forms and Strengths

Plicamycin is available in the following dosage form:

1. Injectable solution: 2.5 mg vial

Administration Instructions for Plicamycin

Plicamycin is administered through an intravenous (IV) infusion, meaning it is delivered directly into a vein. This medication is typically given in a hospital or clinic setting by a trained healthcare professional. It is essential to follow all instructions provided by your doctor or nurse during treatment. If you have any questions about your therapy or experience side effects, contact your healthcare provider immediately. Our telemedicine team is also available to address any concerns you may have.

Plicamycin Side Effects and Adverse Reactions

As with all medications, Plicamycin may cause side effects. While some are relatively common, others are rare but potentially serious. It is important to report any side effects to your healthcare provider promptly. If you experience severe reactions, seek medical attention without delay.

Common Side Effects of Plicamycin

1. Nausea and vomiting: Feeling nauseous or experiencing vomiting is a frequent side effect. Your doctor may prescribe medications to help manage these symptoms.
2. Loss of appetite: A reduced appetite is another common side effect. Eating small, frequent meals can help you maintain your energy and strength.
3. Low blood platelet count (thrombocytopenia): This condition can increase your risk of bleeding. Your doctor will regularly monitor your blood counts to ensure your safety.

Serious Side Effects of Plicamycin

1. Liver toxicity: Plicamycin can affect liver function. Your doctor will monitor this closely through blood tests during treatment.
2. Kidney problems: This medication may impact kidney function. Your healthcare provider will perform regular tests to check your kidney health.
3. Severe bleeding: A lowered platelet count can increase the risk of significant bleeding. Contact your doctor immediately if you notice unusual bruising or bleeding.

Contraindications

A contraindication refers to a condition or circumstance in which using a medication, such as Plicamycin, could pose significant risks to the patient. If you have any of the following conditions, it is essential to avoid taking Plicamycin. Always consult your healthcare provider before starting or discontinuing any medication to ensure your safety.

Pregnancy: Plicamycin is strictly contraindicated during pregnancy due to its potential to harm the developing fetus. This chemotherapy drug can cause birth defects or other serious complications, making it unsafe for use in expectant mothers.

Severe liver disease: Since Plicamycin is processed by the liver, individuals with severe liver disease may be unable to metabolize the medication properly. This can lead to an increased risk of toxic effects and complications.

Severe kidney disease: Plicamycin is eliminated from the body through the kidneys. For patients with severe kidney disease, the drug may accumulate in the body, significantly increasing the likelihood of adverse effects.

Low platelet count (thrombocytopenia): Plicamycin can further reduce platelet levels, which are essential for blood clotting. If you already have thrombocytopenia, taking this medication could exacerbate the condition and heighten the risk of bleeding.

Active infection: Plicamycin suppresses the immune system, making it harder for the body to fight infections. If you have an active infection, using this medication could worsen your condition or delay recovery.

Drug-to-Drug Interactions

It is crucial to inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, and dietary supplements. Plicamycin can interact with other substances, potentially leading to harmful effects. Below are some medications that may interact with Plicamycin:

1. Warfarin (Coumadin): Combining Plicamycin with blood thinners like Warfarin can increase the risk of excessive bleeding.
2. Aspirin (Bayer, Ecotrin): Using Plicamycin alongside aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may elevate the likelihood of bleeding complications.
3. Heparin: Similar to Warfarin, Heparin is a blood thinner, and its use with Plicamycin can significantly raise the risk of severe bleeding.
4. Digoxin (Lanoxin): Plicamycin may reduce the effectiveness of Digoxin, a medication commonly prescribed to manage certain heart conditions.
5. Diuretics (Lasix, Hydrochlorothiazide): Plicamycin can interact with diuretics, increasing the risk of electrolyte imbalances, particularly low calcium levels, which can lead to additional complications.

Plicamycin in Pregnancy

Is it safe to take Plicamycin when pregnant?

No, Plicamycin is not safe for use during pregnancy. It is classified as a Category D drug, meaning there is clear evidence of risk to the fetus. Plicamycin can cause birth defects and other severe complications. If you are pregnant or planning to become pregnant, consult your healthcare provider immediately to discuss safer alternatives. If you are already taking Plicamycin and discover you are pregnant, contact your healthcare provider without delay for guidance on how to proceed.

Plicamycin While Breastfeeding

Is it safe to take Plicamycin while breastfeeding?

No, Plicamycin is not recommended for use while breastfeeding. Although it is not definitively known whether Plicamycin passes into breast milk, the potential for serious side effects in a nursing infant makes its use inadvisable. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore alternative treatments or feeding options that prioritize both your health and your baby’s safety.

Estimated Cost of Plicamycin Medication

The cost of Plicamycin can vary depending on your location and the pharmacy you use. Without insurance, a 30-day supply of Plicamycin is estimated to cost between $1,500 and $2,000 when using a GoodRX coupon. Prices may fluctuate, so it is advisable to check with your pharmacy or use a prescription discount service like GoodRX to obtain the most up-to-date pricing information.

Possible Alternatives to Plicamycin

Depending on the condition being treated, alternative medications or lifestyle adjustments may help manage symptoms effectively. It is essential to consult your healthcare provider before making any changes to your treatment plan. If you’re seeking guidance, consider scheduling a telemedicine visit with one of our providers to explore your options in detail.

Testicular Cancer

For testicular cancer, alternatives to Plicamycin include chemotherapy drugs such as cisplatin, etoposide, or bleomycin. Depending on the stage of the cancer, surgery or radiation therapy may also be appropriate. Your healthcare provider can help you determine the most effective treatment strategy tailored to your specific needs.

Hypercalcemia

In cases of hypercalcemia, treatment options may include bisphosphonates like zoledronic acid or calcitonin. Staying well-hydrated and reducing dietary calcium intake can also help alleviate symptoms. These alternatives may be particularly beneficial if Plicamycin is not suitable for your condition.

Osteosarcoma

For osteosarcoma, commonly used chemotherapy drugs include methotrexate, doxorubicin, and cisplatin. Surgery to remove the tumor is often a critical component of treatment. Your healthcare provider can guide you in weighing the benefits of Plicamycin against other chemotherapy options to develop the best plan for your care.

Lymphoma

Treatment for lymphoma often involves chemotherapy regimens such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), radiation therapy, or targeted therapies like rituximab (Rituxan). Depending on the type and stage of lymphoma, Plicamycin may not be a first-line treatment, and your provider can help you explore more effective alternatives.

Breast Cancer

For breast cancer, treatment options include hormone therapies like tamoxifen, chemotherapy, radiation, or targeted therapies such as trastuzumab (Herceptin). While Plicamycin is not commonly used for breast cancer, your healthcare provider can help you navigate the available options to find the most appropriate treatment for your situation.

Kaposi’s Sarcoma

Treatment for Kaposi’s sarcoma may involve antiretroviral therapy (for patients with HIV), chemotherapy, or radiation therapy. Although Plicamycin has been studied for certain cancers, other therapies are often more effective for managing this condition. Your healthcare provider can recommend the best course of action based on your individual needs.

Multiple Myeloma

For multiple myeloma, alternatives include medications such as lenalidomide (Revlimid) and bortezomib (Velcade), as well as stem cell transplantation. While Plicamycin is not a standard treatment for multiple myeloma, it may be considered in specific cases. Your provider can help determine whether it is a viable option for you.

Ewing’s Sarcoma

Treatment for Ewing’s sarcoma typically involves a combination of chemotherapy, radiation therapy, and surgery. Although Plicamycin is not usually a primary treatment choice, it may be considered as part of a broader therapeutic approach. Discuss your options thoroughly with your healthcare provider to ensure the best possible outcome.

Choriocarcinoma

For choriocarcinoma, chemotherapy drugs such as methotrexate or dactinomycin are commonly used. In some cases, surgery may also be necessary. While Plicamycin might be an option in rare circumstances, your healthcare provider can help you evaluate its potential role in your treatment plan.

Wilms’ Tumor

Treatment for Wilms’ tumor often involves surgery to remove the tumor, followed by chemotherapy or radiation therapy, depending on the stage of the disease. Plicamycin is not a standard treatment for this condition, but your healthcare provider can discuss alternative therapies that may be more effective for your child’s care.

Recent Updates on Plicamycin Research

Recent studies on Plicamycin have focused on its potential applications in treating certain cancers and hypercalcemia. Although Plicamycin has been in use for decades, researchers are now exploring its effectiveness when combined with newer therapies. For example, some studies are investigating whether Plicamycin can improve outcomes when paired with immunotherapy drugs. These findings may expand the drug’s role in modern oncology.

Additionally, scientists are delving deeper into the mechanisms of Plicamycin to better understand how it interacts with cancer cells and calcium metabolism. This research could pave the way for more targeted and precise applications of the drug in the future. However, further studies are needed to confirm these findings and establish the safest and most effective ways to incorporate Plicamycin into treatment protocols.

Staying informed about the latest research is vital, especially if you are currently taking Plicamycin. Be sure to discuss any new developments with your healthcare provider. If you have questions or would like to review your treatment plan, you can schedule a telemedicine visit with one of our providers to explore any new options that may be available to you.

James Kingsley

Learn More